Virtual Medicinal Product (VMP) - Mesalazine 500mg modified-release tablets

Name Details

Name Start Date End Date
Name Current Name Mesalazine 500mg modified-release tablets Start Date 19-11-2002 End Date

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1
UDFS UOM
tablet
Unit Dose UOM
tablet

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Oral
Form
Modified-release tablet
Ontology Form/Route
tabletmodified-release.oral
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
A07EC02
BNF Start Date End Date
Current BNF 01050100 Start Date 04-04-2022 End Date
Previous BNF 01050100 Start Date 06-03-2009 End Date 03-04-2022
Previous BNF 01050000 Start Date 02-02-2005 End Date 05-03-2009
SNOMED Codes
Code Start Date End Date
39109811000001104 21-10-2020
317406007 19-11-2002 20-10-2020

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Mesalazine Based on Ingredient Substance 500 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
50 tablet
100 tablet 3074 Part VIIIA Category C